Applied Materials has snapped out of its three-week consolidation, gaining 7.4% on the week to $595.70, as a wave of analyst target upgrades collides with an options market that remains unusually defensive.
The analyst community has been moving in one direction with rare unanimity. UBS raised its target to $705 from $570 today, maintaining a Buy. That follows Needham lifting to $740 and TD Cowen to $700 last Thursday, and Stifel to $650 the same day. Every firm that has published on AMAT this week and last has raised its target — not a single cut. The consensus target now stands at $623, roughly 4.5% above the current price, though several of the more bullish calls (Susquehanna at $900, Cantor Fitzgerald at $850) sit well clear of the pack and suggest some dispersion in how aggressively the Street is willing to underwrite the AI-driven equipment cycle. Morgan Stanley, the notable holdout on conviction, raised its target to $647 but kept an Equal-Weight rating — a reminder that not everyone is leaning fully into the bull case. The core debate is familiar: bulls point to AMAT's dominant position in wafer fabrication equipment and its exposure to gate-all-around adoption and AI-related capex from TSMC, Intel, and Samsung; bears flag the company's meaningful weight in mature-node logic, where growth expectations remain moderate.
The positioning picture is more nuanced than the price action suggests. Short interest is now 2.4% of the free float — low by any standard and continuing the sharp unwind documented last week, when positions fell 15% in five sessions. That covering has continued: short interest dropped another 14% over the past week to roughly 18.8 million shares, the lightest positioning in six weeks. Borrow conditions reflect this cleanly. Cost to borrow has fallen 25% over the week to just 0.35%, and availability is at the loosest end of the spectrum — there is no squeeze pressure here, and the lending market is generating no signal worth trading on. The ORTEX short score has also edged lower, easing from 33.1 a fortnight ago to 31.4 today, consistent with shorts gradually losing conviction.
Options tell a different story. Despite the rally, traders are carrying the most defensive put/call ratio of the past year — the PCR hit 1.2151 on Thursday, just off the 52-week high, and closed Tuesday at 1.21, running 1.6 standard deviations above its 20-day average of 1.07. That is a meaningful divergence. The stock is up 7% on the week, shorts are covering, and analysts are lifting targets — yet options buyers are paying up for downside protection at a rate that implies investors are not fully comfortable holding the move into earnings. The next quarterly print is scheduled for August 13, and the most recent result in May produced essentially no next-day move and a mild five-day drift of -2.1%, suggesting the market has struggled to find a clear catalyst from the earnings event itself in recent history.
Valuation has re-rated alongside the price. The P/E has expanded by roughly 12 points over the past 30 days to 45.5, and price-to-book has moved to 17.1 — elevated multiples that reflect both the re-rating of the semiconductor equipment sector broadly and AMAT's specific leverage to the AI infrastructure build. Among close peers, LRCX gained 6.1% on the week and KLAC 6.4%, keeping the equipment group broadly in step. Smaller names moved more sharply: UCTT jumped 14.3% and ONTO 14.1%, suggesting that the risk-on rotation within the sector is reaching deeper into the cap structure.
The question heading into August is whether the options defensiveness resolves as earnings approach — and whether the Street's target-upgrade cycle has already priced in the next beat, or is still catching up to a multi-quarter re-rating that has further to run.
See the live data behind this article on ORTEX.
Open AMAT on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.